BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yang HY, Du YX, Hou YJ, Lu DR, Xue P. Hyperprogression after anti-programmed death-1 therapy in a patient with urothelial bladder carcinoma: A case report. World J Clin Cases 2023; 11(28): 6841-6849 [PMID: 37901032 DOI: 10.12998/wjcc.v11.i28.6841]
URL: https://www.wjgnet.com/2307-8960/full/v11/i28/6841.htm
Number Citing Articles
1
AntineoplasticsReactions Weekly 2023; 1982(1): 44 doi: 10.1007/s40278-023-48981-y
2
Shenrui Guo, Zhen Tan, Wenbin Guan, Yafu Yin. Early Hyperprogression of Rhabdomyosarcoma Detected by 18F-FDG PET/CT Three Weeks after CAR-T TreatmentWorld Journal of Nuclear Medicine 2024; 23(03): 212 doi: 10.1055/s-0044-1787537